Pontificia Universidade Católica do RS Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2014
NCT02113696
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Centro de Obesidade Mórbida da Pontificia Universidade Católica do RS

Active Ingredients

Drugs in Other Trials (1)

icosapent ethyl (vascepa) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1